The Medical Brief
Evidence-based medicine, made clear. Each week, The Medical Brief breaks down important studies, emerging treatments, diseases, and the science shaping modern healthcare. Clear context, careful explanations, and no sensationalism. For educational purposes only, not medical advice. Brought to you by Jellypod.
Spotify
Apple PodcastsEpisodes (26)
Beyond GLP-1: The Next Wave of Obesity Drugs
Aspirin After Joint Replacement: The EPCAT III Shift
Oxygen After Cardiac Arrest: What the LOGICAL Trial Found
Gene Silencing vs Stabilization in ATTR Cardiomyopathy
Are Beta-Blockers Still Needed After a Heart Attack?
Teclistamab in Early Myeloma Relapse: Promise and Peril
PCSK9 Inhibitors in Primary Prevention
CHAMPION-AF: Can a Heart Device Replace Blood Thinners?
Valproate, Paternal Risk, and the Confounding Mirage
Why Delaying STEMI Reperfusion Fell Flat
Magnetic Shunt Trial Solves a 60-Year NPH Mystery
When Cross-Protection Fails: The GoGoVax Reality Check
YEARS in Cancer Patients: What the Hydra Trial Really Means
Once-Weekly HIV Therapy: A New Era for Adherence
Finerenone’s New Role in HFpEF and HFmrEF
Baxdrostat and the New Frontier in Resistant Hypertension
CREST 2 and the Asymptomatic Carotid Dilemma
Iptacopan in IgA Nephropathy: Slowing Kidney Failure
Fixed-Duration Therapy Challenges Continuous CLL Treatment
EARLY TAVR and the Asymptomatic Paradox
Do Shock Patients Need an Arterial Line Right Away?
Bicarbonate in Shock: Why Fixing the pH Isn’t Enough
C-TRACT Trial: Stenting Gains, Bleeding Costs
Finerenone in Non-Diabetic CKD: FIND-CKD Explained
KarXT and the End of Dopamine-Only Schizophrenia Treatment
